Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acucela, Inc.
University of Washington signs licensing agreement for study of eye disease
September 10th, 2003
The University of Washington (UW) has signed an exclusive patent license with Acucela, Inc., for technology used in the study of potential treatments for eye disease. Acucela, a pharmaceutical start-up company in Seattle, was founded by Dr. Ryo Kubota, a former UW faculty member. Kubota said that as a practicing ophthalmologist in Japan, he became frustrated with the lack of treatments for eye diseases. Kubota left his practice for scientific research at the UW, where he joined the lab of Dr. Thomas Reh, a professor of biological structure, as an acting research assistant professor of ophthalmology. Along with Dr. Andrew Fischer, a senior fellow in the lab, Kubota...
Source: Biotech Week (2003-09-10)
|
